about
Utilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study.Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacySurvival increases with CPR by Emergency Medical Services before defibrillation of out-of-hospital ventricular fibrillation or ventricular tachycardia: observations from the Resuscitation Outcomes Consortium.MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load.Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine designPooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials.Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells.Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.Reply to Dunning.Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.Surrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice Definition.A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine RegimensComparing and combining biomarkers as principle surrogates for time-to-event clinical endpoints.Augmented trial designs for evaluation of principal surrogates.Who really gets strep sore throat? Confounding and effect modification of a time-varying exposure on recurrent events.A boundary-optimized rejection region test for the two-sample binomial problem.Causal estimands and confidence intervals associated with Wilcoxon-Mann-Whitney tests in randomized experimentsResponse to letter by Antonio Martín Andrés on “A boundary-optimized rejection region test for the two-sample binomial problem”Optimizing and evaluating biomarker combinations as trial-level general surrogatesProspective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people with HIV and severe lymphopeniaA unified evaluation of differential vaccine efficacyA Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)
P50
Q30243982-7152C877-0388-492F-9E05-4C6A34A4173FQ30714941-E5C1E073-BA59-4434-BDD7-AB7ABD2D28B1Q33624354-888A2D0F-F843-4CD4-904A-5AEE29961035Q34405131-D8429F18-7472-4ECB-A96B-DF2B8CD497B2Q34430200-6731D228-8929-4DB0-9832-5D64ECA6CB99Q34760497-6023FEF7-6955-4217-869F-CBDD0B285F87Q35919760-636D92A4-1D6F-4391-B44A-32C8BE9C8CE5Q36122365-E8D22981-9CF9-44D8-960E-F984820AB272Q36165265-CBF92661-AB1B-44A0-8EE6-F57F8DDBEC2FQ36181418-5AF042F7-1160-4EBB-9244-62E9730BE127Q36218701-2F900D88-0310-4ACF-B9A8-9BD540D4E5F8Q36407392-FA65FAEF-43F9-4C20-8DBA-2590763A1848Q36413788-3B5C397A-506D-485E-973C-DF428EFE435CQ36711209-CCE31596-28E6-4971-A868-61AF3D4AF74AQ37025729-7BCDDE9E-252D-4657-9DA8-06D2BF46C7DEQ39676457-D0E2ED33-D7B6-45E8-B51C-6E85CEA21A3AQ47245372-3272B574-6A35-463B-9E69-BDF316DC103FQ56940645-B1DC3C14-6326-4297-B5CD-E42E8650FBD8Q56940656-1BCE7F5A-976F-44E4-814A-987C21635F4BQ57286668-1449C3E4-7004-4788-AC2F-7FEB2264306FQ90026407-12E1FC0F-46AF-456D-BB4C-F696C2BD2EB1Q92202559-FD78EB36-0602-44A9-ABE4-C2864F48A289Q92842024-A0DEE16C-9988-4F6C-849C-E8049E94DED2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Erin Gabriel
@ast
Erin Gabriel
@en
Erin Gabriel
@es
Erin Gabriel
@nl
type
label
Erin Gabriel
@ast
Erin Gabriel
@en
Erin Gabriel
@es
Erin Gabriel
@nl
prefLabel
Erin Gabriel
@ast
Erin Gabriel
@en
Erin Gabriel
@es
Erin Gabriel
@nl
P106
P21
P31
P496
0000-0002-0504-8404